MedicAlert Foundation Identifies New Services and Offerings

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MedicAlert Foundation Identifies New Services and Offerings With Help From Oracle Applications

DENVER, CO--(Marketwired - Apr 10, 2013) - COLLABORATE 13 -- Oracle ( NASDAQ : ORCL )

News Facts

  • To expand its medical information services and offerings, MedicAlert Foundation , a global nonprofit organization, has adopted the Oracle E-Business Suite 12.1, Oracle Business Intelligence Applications, Oracle Master Data Management and Oracle Customer Relationship Management.
  • MedicAlert Foundation provides emergency medical information and identification services about its members to emergency medical and law enforcement personnel through its innovative, reliable MedicAlert ID solution.
  • To meet member demand for new ways to leverage critical information and services, MedicAlert needed to replace its rigid legacy system with a modern business platform that could optimize the management of financial and customer information.
  • After a competitive search of vendors, MedicAlert determined only Oracle could deliver the functional and technical requirements to seamlessly integrate its internal Emergency Medical Information Record (EMIR) system and customer-facing operations into a single, secure platform. MedicAlert selected Oracle applications to replace several disparate business systems including a legacy Microsoft Great Plains for Financials and a homegrown system for call center and manufacturing operations.
  • Working with Oracle PartnerNetwork (OPN) Platinum -level member DAZ Systems , and leveraging Oracle Business Accelerators , MedicAlert implemented the Oracle E-Business Suite 12.1 including Financials, Oracle Order Management, Oracle Discrete Manufacturing, Oracle Purchasing, and Oracle CRM, in less than seven months, five months faster than anticipated.
  • Oracle Business Accelerators are powerful, cloud-based rapid implementation tools that dramatically reduce the time and effort required for project scoping, solution design, configuration, and testing. Oracle Business Accelerators incorporate leading industry practices and are available through Oracle's approved partner channel and Oracle Consulting groups.
  • With its new technology platform and the assistance of eVerge Group , a Platinum -level member of Oracle PartnerNetwork, MedicAlert has been able to open up new business opportunities and extend partnerships by having consolidated, authoritative information that provides a single view to accurate information between its EMIR and its CRM applications through Oracle Master Data Management (MDM) which includes Oracle Customer Hub .
  • In addition, by leveraging Oracle Enterprise Data Quality MedicAlert has improved the quality, consistency and relevance of underlying data, providing greater value for analytics and reporting insights through Oracle Business Intelligence .
  • Lastly, by storing sensitive medical information in Oracle CRM, MedicAlert can more easily meet critical regulations around privacy and security, including HIPAA requirements.

Supporting Quotes

  • "Our foundation depends on delivering medical information to stakeholders at critical moments, so having efficient and secure technology to support our business is mandatory," said Karen Lamoree, COO, MedicAlert. "With Oracle, MedicAlert has the platform to extend our services to meet new member needs and grow our business. For example, we've already established new partnerships, generated new business opportunities and enhanced our call center experience."
  • "Timeliness and agility are important for most midsize organizations, but for companies in the medical emergency field like MedicAlert, speed and accuracy are everything," said Steve Cox, vice president, Oracle Accelerate for Midsize Companies. "Oracle Business Accelerators allowed MedicAlert to gain value from Oracle Applications forty percent faster than a traditional deployment. This makes a huge difference, enabling the company to enhance its customer experience and take advantage of growth opportunities right away."

Supporting Resources

About Oracle Accelerate Oracle Accelerate provides simple to deploy, packaged, enterprise-class software solutions to growing midsize organizations through Oracle's network of expert partners. Created by Oracle's expert partners, Oracle Accelerate solutions are simple to deploy, industry-specific packaged solutions, designed for fast time to benefit, which means getting the right solution in place quickly, inexpensively and with a controlled scope and predictable returns. The best Oracle Accelerate Solutions are based on Oracle Business Accelerators, which are powerful, cloud-based rapid implementation tools developed and maintained by Oracle to get you up and running on a wide range of Oracle Applications, both quickly and reliably. Oracle has more than 290,000 midsize customers who buy Oracle to grow. To find out more, visit www.oracle.com/accelerate .

About Oracle Oracle engineers hardware and software to work together in the cloud and in your data center. For more information about Oracle ( NASDAQ : ORCL ), visit www.oracle.com . 

Trademarks Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

Contact Info Danielle Cormier-Smith Oracle +1.610.766.3463 Email Contact Joan Levy Blanc & Otus +1.415.856.5110 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 16

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 12

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women Through the Gettysburg Salon Experience

Updated Category News Views 116

Reimagining Women's Spaces Through the Gettysburg Salon The Gettysburg Salon is a vibrant platform where women can express themselves creatively and engage in thought-provoking dialogues. This initiative began with three passionate individuals who envisioned a safe space for women to explore their identities, aspirations, and challenges through art and conversation. In a...

Continue Reading
Transforming Off-Road Adventures: Upfit UTV and OMI Innovation

Updated Category News Views 165

Transforming Off-Road Adventures: Upfit UTV and OMI Innovation Upfit UTV, a subsidiary of Fox Factory known for customizing high-performance vehicles, has joined forces with OMI, a leader in electric powertrain engineering. Together, they are redefining off-road adventures with their groundbreaking Fusion-Drive technology. This innovation not only elevates performance but...

Continue Reading
Investor Alert: AstraZeneca Faces Class Action Lawsuit Under SEC Laws

Updated Category News Views 278

Investor Alert Regarding AstraZeneca Securities Class Action Kahn Swick & Foti, LLC, founded by former Attorney General Charles C. Foti, Jr., is highlighting crucial information for investors in AstraZeneca PLC (NASDAQ: AZN) who may have incurred losses exceeding $100,000. The firm reminds those affected that they need to file lead plaintiff applications for their class...

Continue Reading
Important Class Action for GSK plc Investors: Know Your Rights

Updated Category News Views 208

GSK Faces Class Action Lawsuit: Key Information for Investors Levi & Korsinsky, LLP has announced a class action securities lawsuit involving GSK plc, a well-known pharmaceutical company traded on the NYSE under the ticker GSK. This lawsuit is particularly significant for investors who have been adversely affected during a specified period concerning the securities of...

Continue Reading
Denny’s Fundraiser for No Kid Hungry: Making a Difference

Updated Category News Views 435

Denny’s Annual Fundraiser for No Kid Hungry Returns Denny’s is excited to bring back its annual in-restaurant fundraiser to support No Kid Hungry, a national initiative focused on ending childhood hunger in the United States. This campaign will run for a designated period, allowing Denny's restaurants to make a meaningful difference by ensuring that children have...

Continue Reading